Kerala

Technical Eval

Goods

Medicines

e-tender for the procurement of Anticancer drugs for the year 2026-27

Kerala Medical Services Corporation Ltd

Thiruvananthapuram, Kerala

Amount: Refer DocsCloses: 9 Jan 20267 Jan 2026Closed

Timeline

Published12 Dec 2025
Closed9 Jan 2026
Technical Evaluation29 Jan 2026
Award—

Bids

12 Bids29 Jan 2026

#	Company	Status
1	ADMAC LIFESCIENCES Accepted-Technical	Accepted-Technical details in notice
2	Beta Drugs Limited Accepted-Technical NA \| NA \| NA \| 121004	Accepted-Technical details in notice
3	BRUCK PHARMA PVT LTD Accepted-Technical	Accepted-Technical details in notice
4	Dr.Reddys LAboratories Limited Accepted-Technical 7 1 27 AMEERPET HYDERABAD TELANGANA INDIA 500016 \| HYDERABAD \| HYDERABAD \| TELANGANA \| 500016	Accepted-Technical Details in notice
5	EMCURE PHARMACEUTICALS LIMITED Accepted-Technical	Accepted-Technical details in notice

Corrigenda

Corrigendum

3 updatesLatest on 7 Jan 2026Submission Ends:7 Jan 20269 Jan 2026

Date changes

Download Ends7 Jan 20269 Jan 2026Clarification Ends7 Jan 20269 Jan 2026Submission Ends7 Jan 20269 Jan 2026

Tender Value

Refer Docs

EMD Value

₹50,000

Closing Date

9 Jan 2026, 5:00 pmClosed

Tender Inviting Organisation

Name

Managing Director

Address

KMSCL,THYCAUD

Work Description

e-tender for the procurement of Anticancer drugs for the year 2026-27

Tender Information

Tender ID

2025_KMSCL_821819_1

Reference Number

KMSCL/ED/ACD/RC/2025/030

Tender Type

Open Tender

Product Category

Medicines

Form of Contract

Item Wise

Period of Work

365 days

Location

Thiruvananthapuram

Source Website

Subscribe to view

Eligibility / Pre-Qualification

Please refer tender document

Documents Required

22 documents required · 22 mandatory

Fee/PreQual/Technical

RequiredCheck list in Anx 1 (.pdf)

RequiredDocumentry proof that the firm has claimed for exemption as per sl no 2 of Anx 1 (.pdf)

RequiredThe details of offline EMD submitted as per sl no 3 of Anx 1 (.pdf)

RequiredThe details of Re-inspection fee as per sl no 4 of Anx 1 (.pdf)

RequiredThe details of factory inspection as per sl no 5 of Anx 1 (.pdf)

RequiredBid offer form as per sl no 6 of Anx 1 (.pdf)

RequiredBid offer form as per sl no 7 of Anx 1 (.xls)

RequiredNotary attested copy of annual turnover stamt as per sl no 8 of Anx 1 (.pdf)

RequiredNotary attested copy of manufacturing license as per sl no 9 of Anx 1 (.pdf)

RequiredNotary attested copy of valid import license as per sl no 10 of Anx 1 (.pdf)

RequiredNotarty attested copy of market standing certificate as per sl no 11 of Anx 1 (.pdf)

RequiredNotary attested copy of valid license as per sl no 12 of Anx 1 (.pdf)

RequiredNotary attested copy of valid WHO gmp certificate as per sl no 13 of Anx 1 (.pdf)

RequiredNotary attested copy of current non conviction certificate as per sl no 14 of Anx 1 (.pdf)

RequiredNotary attested performance as per sl no 15 of Anx 1 (.pdf)

RequiredNotary attested copy of Power of attorney as per sl no 16 of Anx 1 (.pdf)

RequiredNotary attested copy of undertaking as per sl no 17 of Anx 1 (.pdf)

RequiredNotary attested of undertaking as per sl no 18 of Anx 1 (.pdf)

RequiredNotary attested copy of Audited balance sheets and P and L stmt as per sl no 19 of Anx 1 (.pdf)

RequiredNotary attested details of technical personnel as per sl no 20 of Anx 1 (.pdf)

RequiredNotary attested details of the bidder as per sl no 21 of Anx 1 (.pdf)

Finance

RequiredPrice bid format (.xls)

Fee & Financial Details

Tender Fee Amount

₹29,500

Tender Fee Exemption Allowed

Yes

EMD Fee Amount

₹50,000

EMD Fee Exemption Allowed

Yes

Pre-Bid Meeting

Meeting Place

online platform

Important Dates

Last Activity

29 Jan 2026

Published

12 Dec 2025

Bid Opening

12 Jan 2026

Download Starts

12 Dec 2025

Download Ends

9 Jan 2026

Submission Starts

12 Dec 2025

Clarification Period

12 Dec 2025 - 9 Jan 2026

Pre-Bid Meeting

18 Dec 2025

BOQ Preview

•

ANASTRAZOLE TAB IP 1 mg

•

AZATHIOPRINE TAB IP 50 mg

•

BICALUTAMIDE TAB IP 50 mg

•

BLEOMYCIN INJ IP 15 Units

•

CARFILZOMIB INJ 30 mg

•

CETUXIMAB INJ 100 mg

•

CYCLOPHOSPHAMIDE TAB IP 50 mg

•

DACARBAZINE INJ IP/USP 200 mg

•

DACTINOMYCIN INJ 0.5 mg/3 ml

•

DAUNORUBICIN INJ IP 20 mg

•

DEXAMETHASONE TAB IP 8 mg

•

DEXAMETHASONE TAB IP 4 mg

•

DOXORUBICIN (PEGYLATED LIPOSOMAL) INJ 20 mg

•

DOXORUBICIN (PEGYLATED LIPOSOMAL) INJ 50 mg

•

ENZALUTAMIDE CAP 80 mg

•

ERIBULIN INJ 0.44 mg/ml

•

IBANDRONATE TAB 50 mg

•

MEGESTROL ACETATE TAB IP/BP/USP 40 mg

•

MELPHALAN TAB IP 5 mg

•

MERCAPTOPURINE TAB IP 50 mg

•

MESNA INJ 200 mg

•

METHOTREXATE INJ (INTRATHECAL, PRESERVATIVE FREE) 15 mg

•

METHOTREXATE TAB IP 2.5 mg

•

MITOMYCIN FOR INJ IP/USP 10 mg

•

MITOXANTRONE INFUSION BP/USP 20 mg

•

POMALIDOMIDE CAP 2 mg

•

PROCARBAZINE HCL CAP IP 50 mg

•

PROTEIN BOUND PACLITAXEL INJ 100 mg

•

REGORAFENIB TAB 40 mg

•

RUCAPARIB TAB 300 mg

•

SORAFENIB TOSYLATE TAB IP 200 mg

•

TAMOXIFEN TAB IP 20 mg

•

TEGAFUR +URACIL CAP 100 mg + 224 mg

•

THALIDOMIDE CAP USP 100 mg

•

VINBLASTINE SULPHATE INJ IP 10 mg

•

VINCRISTINE SULPHATE INJ IP/USP 1 mg

•

ZOLEDRONIC ACID INJ IP 4 mg

•

CYCLOPHOSPHAMIDE INJ IP 200 mg

•

CYCLOPHOSPHAMIDE INJ IP 500 mg

•

CYCLOPHOSPHAMIDE INJ IP 1 gm

•

DECITABINE INJ 50 mg

•

DECITABINE INJ 30 mg

•

EVEROLIMUS TAB 10 mg

•

EVEROLIMUS TAB 5 mg

•

FLUROURACIL INJ IP 250 mg

•

FLUROURACIL INJ IP 500 mg

•

LEUCOVORIN CALCIUM INJ IP 50 mg

•

LEUCOVORIN CALCIUM INJ IP 15 mg

•

OCTREOTIDE INJ 30 mg

Stage Documents

Technical Evaluation

tech_eval.pdf

PDF

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

html • 0.04 MB

NIT Documents

Tendernotice_1.pdf

PDF • 0.42 MB

Work Item Documents

ACD.pdf

Tender Documents • 2.92 MB

BOQ_1377492.xls

BOQ • 0.36 MB

Ready to Participate?

Download all tender documents and submit your bid

Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .